ロード中...
A Randomized Trial Comparing Disease Activity Measures for the Assessment and Prediction of Response in Rheumatoid Arthritis Patients Initiating Certolizumab Pegol
OBJECTIVE: The aim of the Patient/Physician Reported Efficacy Determination In Clinical Practice Trial (PREDICT; ClinicalTrials identifier NCT01255761) was to compare the patient‐reported Routine Assessment of Patient Index Data 3 (RAPID‐3) instrument with the investigator‐based Clinical Disease Act...
保存先:
| 出版年: | Arthritis Rheumatol |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5063165/ https://ncbi.nlm.nih.gov/pubmed/26316013 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.39322 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|